| mRNA |
piperlongumine |
GDSC1000 |
pan-cancer |
AAC |
-0.066 |
0.05 |
| mRNA |
Doxorubicin |
CTRPv2 |
pan-cancer |
AAC |
-0.063 |
0.05 |
| mRNA |
VX-702 |
GDSC1000 |
pan-cancer |
AAC |
-0.071 |
0.05 |
| mRNA |
NVP-231 |
CTRPv2 |
pan-cancer |
AAC |
-0.068 |
0.05 |
| mRNA |
BRD9876:MK-1775 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.32 |
0.05 |
| mRNA |
PF-184 |
CTRPv2 |
pan-cancer |
AAC |
-0.069 |
0.05 |
| mRNA |
Erlotinib |
UHNBreast |
pan-cancer |
AAC |
-0.53 |
0.05 |
| mRNA |
BRD-K97651142 |
CTRPv2 |
pan-cancer |
AAC |
0.077 |
0.05 |
| mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.058 |
0.05 |
| mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.077 |
0.05 |